Kristen Fortney's most recent trade in BioAge Labs Inc. was a trade of 530,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioAge Labs Inc. | Kristen Fortney | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 530,000 | 530,000 | - | - | Stock Option (Right to Buy) | |
| BioAge Labs Inc. | Kristen Fortney | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2024 | 708,044 | 708,044 | - | - | Stock Option (Right to Buy) | |
| BioAge Labs Inc. | Kristen Fortney | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2024 | 424,827 | 424,827 | - | - | Stock Option (Right to Buy) |